The Patent Finder

Paragon Therapeutics, Inc.

Also on record
Records under this name other than the patents Paragon Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.

Back to Paragon Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
18/917,838FCRN Antagonists with Improved Half-Life and Methods of Use
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/069,168FC Fragments That Bind FCRN and Methods of Use
Abandoned
Abandoned Jan 9, 2026
AbandonedAbandoned Jan 9, 2026
19/157,017Antibodies That Bind Interleukin 4 Receptor Alpha and Methods of Use
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/297,947FC Fragments That Bind FCRN and Methods of Use
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/302,809Long Acting ALPHA4BETA7 Targeting Molecule Compositions for the Treatment Gastrointestinal Inflammatory Disease
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/324,344IL-17 Binding Proteins, Compositions, and Methods of Use Thereof
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/355,961Albumin Binding Proteins and Methods of Use
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/376,465TL1A Binding Proteins and Methods of Use
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/393,395Long Acting ALPHA4BETA7 Targeting Molecule Compositions for the Treatment Gastrointestinal Inflammatory Disease
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/406,490TL1A Binding Proteins and Methods of Use
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
10 of 19 records shown.
Pro members see all 19.
Pro members: see all 19 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited